MTB
BIO icon

Mizuho Trust & Banking’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mizuho Trust & Banking’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,100
Closed -$1.33M – 100
2016
Q3 		$1.33M Hold
8,100
– – ﹤0.01% 683
2016
Q2 		$1.16M Buy
+8,100
New +$1.16M ﹤0.01% 692

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Mizuho Trust & Banking's BIO Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2016, closing a stake of 8,100 shares — an estimated $1.33M sold.

Mizuho Trust & Banking first reported a position in BIO in Q2 2016 and held it in 2 quarters. The position peaked at $1.33M in Q3 2016. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining Bio-Rad Laboratories Class A position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 8,100 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $1.33M.
  • Mizuho Trust & Banking first reported a position in Bio-Rad Laboratories Class A in Q2 2016 and held it in 2 quarters.
  • Mizuho Trust & Banking's Bio-Rad Laboratories Class A position peaked at $1.33M in Q3 2016.
  • 261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.